Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5282523
Max Phase: Preclinical
Molecular Formula: C58H73N13O9
Molecular Weight: 1096.30
Associated Items:
ID: ALA5282523
Max Phase: Preclinical
Molecular Formula: C58H73N13O9
Molecular Weight: 1096.30
Associated Items:
Canonical SMILES: CCCC[C@H](NC(C)=O)C(=O)N[C@H]1CC(=O)NCCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc3ccccc3c2)NC(=O)[C@H]2Cc3ccccc3CN2C1=O
Standard InChI: InChI=1S/C58H73N13O9/c1-3-4-19-44(65-34(2)72)52(75)70-48-31-50(73)62-25-12-11-21-43(51(59)74)66-55(78)47(29-40-32-64-42-20-10-9-18-41(40)42)68-53(76)45(22-13-26-63-58(60)61)67-54(77)46(28-35-23-24-36-14-5-6-15-37(36)27-35)69-56(79)49-30-38-16-7-8-17-39(38)33-71(49)57(48)80/h5-10,14-18,20,23-24,27,32,43-49,64H,3-4,11-13,19,21-22,25-26,28-31,33H2,1-2H3,(H2,59,74)(H,62,73)(H,65,72)(H,66,78)(H,67,77)(H,68,76)(H,69,79)(H,70,75)(H4,60,61,63)/t43-,44-,45-,46+,47-,48-,49+/m0/s1
Standard InChI Key: UVUOMESIOOEXGA-MATBRXERSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1096.30 | Molecular Weight (Monoisotopic): 1095.5654 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Van der Poorten O, Knuhtsen A, Sejer Pedersen D, Ballet S, Tourwé D.. (2016) Side Chain Cyclized Aromatic Amino Acids: Great Tools as Local Constraints in Peptide and Peptidomimetic Design., 59 (24): [PMID:27690430] [10.1021/acs.jmedchem.6b01029] |
Source(1):